Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Christer Halldin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Anatomy

Brain

Chemicals & Drugs

Living Beings

Macaca fascicularis

Concepts & Ideas

Tissue Distribution

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
204
Farde, Lars
56
Swahn, Carl-Gunnar
44
Karlsson, Per
44
Hall, Håkan
42
Sedvall, Göran
41
Gulyás, Balázs
38
Pike, Victor
24
Nyberg, Svante
23
Innis, Robert
21
Nordström, Anna-Lena
18
Sandell, Johan
18
Pauli, Stefan
17
Lundkvist, Camilla
16
Olsson, Hans
16
Någren, Kjell

Sign-in to see all Coauthors

Publications

TOP 3
Takano Akihiro; Gulyás Balázs; Varrone Andrea; Halldin Christer
Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.
Donohue Sean R; Varnäs Katarina; Jia Zhisheng; Gulyás Balázs; Pike Victor W; Halldin Christer
Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.
Terry Garth E; Liow Jeih-San; Zoghbi Sami S; Hirvonen Jussi; Farris Amanda G; Lerner Alicja; Tauscher Johannes T; Schaus John M; Phebus Lee; Felder Christian C; Morse Cheryl L; Hong Jinsoo S; Pike Victor W; Halldin Christer; Innis Robert B
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Christer Halldin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Takano Akihiro; Gulyás Balázs; Varrone Andrea; Halldin Christer
Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.
European journal of nuclear medicine and molecular imaging 2009;36(11):1892-5.
2009: Donohue Sean R; Varnäs Katarina; Jia Zhisheng; Gulyás Balázs; Pike Victor W; Halldin Christer
Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.
Bioorganic & medicinal chemistry letters 2009;19(21):6209-12.
2009: Terry Garth E; Liow Jeih-San; Zoghbi Sami S; Hirvonen Jussi; Farris Amanda G; Lerner Alicja; Tauscher Johannes T; Schaus John M; Phebus Lee; Felder Christian C; Morse Cheryl L; Hong Jinsoo S; Pike Victor W; Halldin Christer; Innis Robert B
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.
NeuroImage 2009;48(2):362-70.
2009: Takano Akihiro; Gulyás Balázs; Varrone Andrea; Halldin Christer
Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.
European journal of nuclear medicine and molecular imaging 2009;36(11):1885-91.
2009: Karlsson Sari; Nyberg Lars; Karlsson Per; Fischer Håkan; Thilers Petra; Macdonald Stuart; Brehmer Yvonne; Rieckmann Anna; Halldin Christer; Farde Lars; Bäckman Lars
Modulation of striatal dopamine D1 binding by cognitive processing.
NeuroImage 2009;48(2):398-404.
2009: Nyberg Svante; Jönhagen Maria Eriksdotter; Cselényi Zsolt; Halldin Christer; Julin Per; Olsson Hans; Freund-Levi Yvonne; Andersson Jan; Varnäs Katarina; Svensson Samuel; Farde Lars
Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.
European journal of nuclear medicine and molecular imaging 2009;36(11):1859-63.
2009: Kannan P; John C; Zoghbi S S; Halldin C; Gottesman M M; Innis R B; Hall M D
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications.
Clinical pharmacology and therapeutics 2009;86(4):368-77.
2009: Varrone Andrea; Steiger Carsten; Schou Magnus; Takano Akihiro; Finnema Sjoerd J; Guilloteau Denis; Gulyás Balázs; Halldin Christer
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
Synapse (New York, N.Y.) 2009;63(10):871-80.
2009: Varrone Andrea; Sjöholm Nils; Eriksson Lars; Gulyás Balazs; Halldin Christer; Farde Lars
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.
European journal of nuclear medicine and molecular imaging 2009;36(10):1639-50.
2009: Schou Magnus; Steiger Carsten; Varrone Andrea; Guilloteau Denis; Halldin Christer
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2009;19(16):4843-5.
2009: Takano Akihiro; Gulyás Balázs; Varrone Andrea; Maguire Ralph Paul; Halldin Christer
Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).
European journal of nuclear medicine and molecular imaging 2009;36(8):1308-14.
2009: Trajkovska Viktorija; Kirkegaard Lisbeth; Krey Gesa; Marcussen Anders B; Thomsen Morten S; Chourbaji Sabine; Brandwein Christiane; Ridder Stephanie; Halldin Christer; Gass Peter; Knudsen Gitte M; Aznar Susana
Activation of glucocorticoid receptors increases 5-HT2A receptor levels.
Experimental neurology 2009;218(1):83-91.
2009: Skinbjerg Mette; Ariano Marjorie A; Thorsell Annika; Heilig Markus; Halldin Christer; Innis Robert B; Sibley David R
Arrestin3 mediates D(2) dopamine receptor internalization.
Synapse (New York, N.Y.) 2009;63(7):621-4.
2009: Borg Jacqueline; Henningsson Susanne; Saijo Tomoyuki; Inoue Makoto; Bah Jessica; Westberg Lars; Lundberg Johan; Jovanovic Hristina; Andrée Bengt; Nordstrom Anna-Lena; Halldin Christer; Eriksson Elias; Farde Lars
Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(6):783-92.
2009: Skinbjerg Mette; Namkung Yoon; Halldin Christer; Innis Robert B; Sibley David R
Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.
Synapse (New York, N.Y.) 2009;63(6):462-75.
2009: Otsuka Tatsui; Ito Hiroshi; Halldin Christer; Takahashi Hidehiko; Takano Harumasa; Arakawa Ryosuke; Okumura Masaki; Kodaka Fumitoshi; Miyoshi Michie; Sekine Mizuho; Seki Chie; Nakao Ryuji; Suzuki Kazutoshi; Finnema Sjoerd; Hirayasu Yoshio; Suhara Tetsuya; Farde Lars
Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(5):703-10.
2009: Finnema Sjoerd J; Halldin Christer; Bang-Andersen Benny; Gulyás Balázs; Bundgaard Christoffer; Wikström Håkan V; Farde Lars
Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
Synapse (New York, N.Y.) 2009;63(5):378-89.
2009: Odano Ikuo; Halldin Christer; Karlsson Per; Varrone Andrea; Airaksinen Anu J; Krasikova Raisa N; Farde Lars
[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil.
NeuroImage 2009;45(3):891-902.
2009: Jovanovic Hristina; Karlsson Per; Cerin Asta; Halldin Christer; Nordström Anna-Lena
5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET.
Psychiatry research 2009;172(1):31-7.
2009: Tokunaga Masaki; Seneca Nicholas; Shin Ryong-Moon; Maeda Jun; Obayashi Shigeru; Okauchi Takashi; Nagai Yuji; Zhang Ming-Rong; Nakao Ryuji; Ito Hiroshi; Innis Robert B; Halldin Christer; Suzuki Kazutoshi; Higuchi Makoto; Suhara Tetsuya
Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(6):1887-96.
2009: Andersson Jan; Truong Phong; Halldin Christer
In-target produced [11C]methane: Increased specific radioactivity.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009;67(1):106-10.
2009: Gulyás Balázs; Makkai Boglárka; Kása Péter; Gulya Károly; Bakota Lidia; Várszegi Szilvia; Beliczai Zsuzsa; Andersson Jan; Csiba László; Thiele Andrea; Dyrks Thomas; Suhara Tetsua; Suzuki Kazutoshi; Higuchi Makato; Halldin Christer
A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.
Neurochemistry international 2009;54(1):28-36.
2009: Finnema Sjoerd J; Donohue Sean R; Zoghbi Sami S; Brown Amira K; Gulyás Balázs; Innis Robert B; Halldin Christer; Pike Victor W
Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
Synapse (New York, N.Y.) 2009;63(1):22-30.
2009: Schou Magnus; Zoghbi Sami S; Shetty H Umesha; Shchukin Evgeny; Liow Jeih-San; Hong Jinsoo; Andrée Bengt A; Gulyás Balázs; Farde Lars; Innis Robert B; Pike Victor W; Halldin Christer
Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(1):23-30.
2009: Krasikova Raisa N; Andersson Jan; Truong Phong; Nag Sangram; Shchukin Evgeny V; Halldin Christer
A fully automated one-pot synthesis of [carbonyl-11C]WAY-100635 for clinical PET applications.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009;67(1):73-8.
2008: Beliczai Zsuzsa; Varszegi Szilvia; Gulyas Balazs; Halldin Christer; Kasa Peter; Gulya Karoly
Immunohistoblot analysis on whole human hemispheres from normal and Alzheimer diseased brains.
Neurochemistry international 2008;53(6-8):181-3.
2008: Verbruggen Alfons; Coenen Heinz H; Deverre Jean-Robert; Guilloteau Denis; Langstrom Bengt; Salvadori Piero A; Halldin Christer
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU.
European journal of nuclear medicine and molecular imaging 2008;35(11):2144-51.
2008: Seneca Nicholas; Zoghbi Sami S; Skinbjerg Mette; Liow Jeih-San; Hong Jinsoo; Sibley David R; Pike Victor W; Halldin Christer; Innis Robert B
Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
Synapse (New York, N.Y.) 2008;62(10):756-63.
2008: Donohue Sean R; Krushinski Joseph H; Pike Victor W; Chernet Eyassu; Phebus Lee; Chesterfield Amy K; Felder Christian C; Halldin Christer; Schaus John M
Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.
Journal of medicinal chemistry 2008;51(18):5833-42.
2008: Donohue Sean R; Pike Victor W; Finnema Sjoerd J; Truong Phong; Andersson Jan; Gulyás Balázs; Halldin Christer
Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.
Journal of medicinal chemistry 2008;51(18):5608-16.
2008: Seneca Nicholas; Skinbjerg Mette; Zoghbi Sami S; Liow Jeih-San; Gladding Robert L; Hong Jinsoo; Kannan Pavitra; Tuan Edward; Sibley David R; Halldin Christer; Pike Victor W; Innis Robert B
Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.
Synapse (New York, N.Y.) 2008;62(9):700-9.
2008: Ciumas C; Wahlin T-B Robins; Jucaite A; Lindstrom P; Halldin C; Savic I
Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy.
Neurology 2008;71(11):788-94.
2008: Paoli J; Halldin C; Ericson M B; Wennberg A-M
Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses.
Clinical and experimental dermatology 2008;33(5):559-64.
2008: Arakawa Ryosuke; Okumura Masaki; Ito Hiroshi; Seki Chie; Takahashi Hidehiko; Takano Harumasa; Nakao Ryuji; Suzuki Kazutoshi; Okubo Yoshiro; Halldin Christer; Suhara Tetsuya
Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1270-6.
2008: Takano Akihiro; Varrone Andrea; Gulyás Balázs; Karlsson Per; Tauscher Johannes; Halldin Christer
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
NeuroImage 2008;42(2):474-82.
2008: Cervenka Simon; Halldin Christer; Farde Lars
Age-related diurnal effect on D2 receptor binding: a preliminary PET study.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(5):671-8.
2008: Airaksinen Anu J; Nag Sangram; Finnema Sjoerd J; Mukherjee Jogeshwar; Chattopadhyay Sankha; Gulyás Balázs; Farde Lars; Halldin Christer
[11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors.
Bioorganic & medicinal chemistry 2008;16(13):6467-73.
2008: Terry Garth; Liow Jeih-San; Chernet Eyassu; Zoghbi Sami S; Phebus Lee; Felder Christian C; Tauscher Johannes; Schaus John M; Pike Victor W; Halldin Christer; Innis Robert B
Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
NeuroImage 2008;41(3):690-8.
2008: Pierson M Edward; Andersson Jan; Nyberg Svante; McCarthy Dennis J; Finnema Sjoerd J; Varnäs Katarina; Takano Akihiro; Karlsson Per; Gulyás Balázs; Medd Amy M; Lee Chi-Ming; Powell Mark E; Heys J Richard; Potts William; Seneca Nicholas; Mrzljak Ladislav; Farde Lars; Halldin Christer
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
NeuroImage 2008;41(3):1075-85.
2008: Hirvonen Jussi; Johansson Jarkko; Teräs Mika; Oikonen Vesa; Lumme Ville; Virsu Pauliina; Roivainen Anne; Någren Kjell; Halldin Christer; Farde Lars; Hietala Jarmo
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(5):1059-69.
2008: Cervenka Simon; Bäckman Lars; Cselényi Zsolt; Halldin Christer; Farde Lars
Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum.
NeuroImage 2008;40(3):1287-95.
2008: Takano Akihiro; Halldin Christer; Varrone Andrea; Karlsson Per; Sjöholm Nils; Stubbs James B; Schou Magnus; Airaksinen Anu J; Tauscher Johannes; Gulyás Balázs
Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.
European journal of nuclear medicine and molecular imaging 2008;35(3):630-6.
2008: Nordstrom Anna-Lena; Mansson Mattias; Jovanovic Hristina; Karlsson Per; Halldin Christer; Farde Lars; Vanover Kimberly E; Hacksell Uli; Brann Mark R; Davis Robert E; Weiner David M
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(2):163-71.
2008: Jovanovic Hristina; Lundberg Johan; Karlsson Per; Cerin Asta; Saijo Tomoyuki; Varrone Andrea; Halldin Christer; Nordström Anna-Lena
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
NeuroImage 2008;39(3):1408-19.
2008: Takano Akihiro; Gulyás Balázs; Varrone Andrea; Karlsson Per; Schou Magnus; Airaksinen Anu J; Vandenhende Francois; Tauscher Johannes; Halldin Christer
Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.
European journal of nuclear medicine and molecular imaging 2008;35(1):153-7.
2008: Vas Adám; Shchukin Yevgeni; Karrenbauer Virginija D; Cselényi Zsolt; Kostulas Kosta; Hillert Jan; Savic Ivanka; Takano Akihiro; Halldin Christer; Gulyás Balázs
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Journal of the neurological sciences 2008;264(1-2):9-17.
2008: Yasuno Fumihiko; Brown Amira K; Zoghbi Sami S; Krushinski Joseph H; Chernet Eyassu; Tauscher Johannes; Schaus John M; Phebus Lee A; Chesterfield Amy K; Felder Christian C; Gladding Robert L; Hong Jinsoo; Halldin Christer; Pike Victor W; Innis Robert B
The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(2):259-69.
2007: Lundberg Johan; Borg Jacqueline; Halldin Christer; Farde Lars
A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
Psychopharmacology 2007;195(3):425-33.
2007: Lundberg Johan; Christophersen Jacob Strøyer; Petersen Kamilla Buchberg; Loft Henrik; Halldin Christer; Farde Lars
PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(6):777-85.
2007: McCarron Julie A; Zoghbi Sami S; Shetty H Umesha; Vermeulen Eric S; Wikström Håkan V; Ichise Masanori; Yasuno Fumihiko; Halldin Christer; Innis Robert B; Pike Victor W
Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
European journal of nuclear medicine and molecular imaging 2007;34(10):1670-82.
2007: Shetty H Umesha; Zoghbi Sami S; Liow Jeih-San; Ichise Masanori; Hong Jinsoo; Musachio John L; Halldin Christer; Seidel Jurgen; Innis Robert B; Pike Victor W
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.
European journal of nuclear medicine and molecular imaging 2007;34(5):667-78.
2007: Stepanov Vladimir; Schou Magnus; Järv Jaak; Halldin Christer
Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2007;65(3):293-300.
2007: Zhang Ming-Rong; Kumata Katsushi; Maeda Jun; Haradahira Terushi; Noguchi Junko; Suhara Tetsuya; Halldin Christer; Suzuki Kazutoshi
N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[(131)I]iodo-5-me thoxybenzyl)acetamide: a potent iodinated radioligand for the peripheral-type benzodiazepine receptor in brain.
Journal of medicinal chemistry 2007;50(4):848-55.
2007: Schou Magnus; Pike Victor W; Sóvágó Judit; Gulyás Balázs; Gallagher Peter T; Dobson David R; Walter Magnus W; Rudyk Helene; Farde Lars; Halldin Christer
Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
Bioorganic & medicinal chemistry 2007;15(2):616-25.
2007: Saba Wadad; Valette Héric; Schöllhorn-Peyronneau Marie-Anne; Coulon Christine; Ottaviani Michele; Chalon Sylvie; Dolle Frédéric; Emond Patrick; Halldin Christer; Helfenbein Julie; Madelmont Jean-Claude; Deloye Jean-Bernard; Guilloteau Denis; Bottlaender Michel
[11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.
Synapse (New York, N.Y.) 2007;61(1):17-23.
2007: Schou Magnus; Pike Victor W; Halldin Christer
Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.
Current topics in medicinal chemistry 2007;7(18):1806-16.
2006: Talvik Mirjam; Nordström Anna-Lena; Okubo Yoshiro; Olsson Hans; Borg Jacqueline; Halldin Christer; Farde Lars
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Psychiatry research 2006;148(2-3):165-73.
2006: Jovanovic Hristina; Cerin Asta; Karlsson Per; Lundberg Johan; Halldin Christer; Nordström Anna-Lena
A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.
Psychiatry research 2006;148(2-3):185-93.
2006: Vander Borght T; Asenbaum S; Bartenstein P; Halldin C; Kapucu O; Van Laere K; Varrone A; Tatsch K;
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.
European journal of nuclear medicine and molecular imaging 2006;33(11):1374-80.
2006: Cselényi Zsolt; Olsson Hans; Halldin Christer; Gulyás Balázs; Farde Lars
A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635.
NeuroImage 2006;32(4):1690-708.
2006: Seneca Nicholas; Gulyás Balázs; Varrone Andrea; Schou Magnus; Airaksinen Anu; Tauscher Johannes; Vandenhende Francois; Kielbasa William; Farde Lars; Innis Robert B; Halldin Christer
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Psychopharmacology 2006;188(1):119-27.
2006: Lundberg Johan; Halldin Christer; Farde Lars
Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
Synapse (New York, N.Y.) 2006;60(3):256-63.
2006: Cervenka Simon; Pålhagen Sven E; Comley Robert A; Panagiotidis Georgios; Cselényi Zsolt; Matthews Julian C; Lai Robert Y; Halldin Christer; Farde Lars
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
Brain : a journal of neurology 2006;129(Pt 8):2017-28.
2006: Musachio John L; Hong Jinsoo; Ichise Masanori; Seneca Nicholas; Brown Amira K; Liow Jeih-San; Halldin Christer; Innis Robert B; Pike Victor W; He Rong; Zhou Jia; Kozikowski Alan P
Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors.
Bioorganic & medicinal chemistry letters 2006;16(12):3101-4.
2006: Jucaite Aurelija; Odano Ikuo; Olsson Hans; Pauli Stefan; Halldin Christer; Farde Lars
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.
European journal of nuclear medicine and molecular imaging 2006;33(6):657-68.
2006: Donohue Sean R; Halldin Christer; Pike Victor W
Synthesis and structure-activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB(1)) receptor ligands for potential use in molecular imaging.
Bioorganic & medicinal chemistry 2006;14(11):3712-20.
2006: Borg Jacqueline; Andrée Bengt; Lundberg Johan; Halldin Christer; Farde Lars
Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions--a strategy in translational psychopharmacology.
Psychopharmacology 2006;185(3):389-94.
2006: Seneca Nicholas; Finnema Sjoerd J; Farde Lars; Gulyás Balázs; Wikström Håkan V; Halldin Christer; Innis Robert B
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
Synapse (New York, N.Y.) 2006;59(5):260-9.
2006: Chalon Sylvie; Hall Hakan; Saba Wadad; Garreau Lucette; Dollé Frédéric; Halldin Christer; Emond Patrick; Bottlaender Michel; Deloye Jean-Bernard; Helfenbein Julie; Madelmont Jean-Claude; Bodard Sylvie; Mincheva Zoïa; Besnard Jean-Claude; Guilloteau Denis
Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
The Journal of pharmacology and experimental therapeutics 2006;317(1):147-52.
2006: Chou Yuan-Hwa; Halldin Christer; Farde Lars
Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
Psychopharmacology 2006;185(1):29-35.
2006: Dollé Frédéric; Emond Patrick; Mavel Sylvie; Demphel Stéphane; Hinnen Françoise; Mincheva Zoïa; Saba Wadad; Valette Heric; Chalon Sylvie; Halldin Christer; Helfenbein Julie; Legaillard Joël; Madelmont Jean-Claude; Deloye Jean-Bernard; Bottlaender Michel; Guilloteau Denis
Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET.
Bioorganic & medicinal chemistry 2006;14(4):1115-25.
2006: Schou Magnus; Sóvágó Judit; Pike Victor W; Gulyás Balázs; Bøgesø Klaus P; Farde Lars; Halldin Christer
Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):1-8.
2005: Halldin Christer; Lundberg Johan; Sóvágó Judit; Gulyás Balázs; Guilloteau Denis; Vercouillie Johnny; Emond Patrick; Chalon Sylvie; Tarkiainen Jari; Hiltunen Jukka; Farde Lars
[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Synapse (New York, N.Y.) 2005;58(3):173-83.
2005: Sóvágó Judit; Farde Lars; Halldin Christer; Schukin Evgenij; Schou Magnus; Laszlovszky István; Kiss Béla; Gulyás Balázs
Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.
Brain research bulletin 2005;67(3):219-24.
2005: Schou Magnus; Halldin Christer; Pike Victor W; Mozley P David; Dobson David; Innis Robert B; Farde Lars; Hall Håkan
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):517-20.
2005: Lundberg Johan; Odano Ikuo; Olsson Hans; Halldin Christer; Farde Lars
Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1505-15.
2005: Seneca Nicholas; Andree Bengt; Sjoholm Nils; Schou Magnus; Pauli Stefan; Mozley P David; Stubbs James B; Liow Jeih-San; Sovago Judit; Gulyás Balazs; Innis Robert; Halldin Christer
Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.
Nuclear medicine communications 2005;26(8):695-700.
2005: Meschaks Anna; Lindstrom Per; Halldin Christer; Farde Lars; Savic Ivanka
Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy.
Archives of neurology 2005;62(6):946-50.
2005: McCarron Julie A; Marchais-Oberwinkler Sandrine; Pike Victor W; Tarkiainen Jari; Halldin Christer; Sóvagó Judit; Gulyas Balàzs; Wikström Hakan V; Farde Lars
Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2005;7(3):209-19.
2005: Finnema Sjoerd J; Seneca Nicholas; Farde Lars; Shchukin Evgeny; Sóvágó Judit; Gulyás Balázs; Wikström Håkan V; Innis Robert B; Neumeyer John L; Halldin Christer
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
Nuclear medicine and biology 2005;32(4):353-60.
2005: Ghose Subroto; Fujita Masahiro; Morrison Paul; Uhl George; Murphy Dennis L; Mozley P David; Schou Magnus; Halldin Christer; Innis Robert
Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.
Synapse (New York, N.Y.) 2005;56(2):100-4.
2005: Gulyás Balázs; Halldin Christer; Vas Adám; Banati Richard B; Shchukin Evgeny; Finnema Sjoerd; Tarkainen Jari; Tihanyi Károly; Szilágyi Géza; Farde Lars
[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.
Journal of the neurological sciences 2005;229-230():219-23.
2005: Zhang Ming-Rong; Maeda Jun; Ito Takehito; Okauchi Takashi; Ogawa Masanao; Noguchi Junko; Suhara Tetsuya; Halldin Christer; Suzuki Kazutoshi
Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[(18)F]fluoromethoxy-d(2)-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor.
Bioorganic & medicinal chemistry 2005;13(5):1811-8.
2005: Ryzhikov Nikolaj N; Seneca Nicholas; Krasikova Raisa N; Gomzina Natalia A; Shchukin Evgeny; Fedorova Olga S; Vassiliev Dmitrij A; Gulyás Balázs; Hall Håkan; Savic Ivanka; Halldin Christer
Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography.
Nuclear medicine and biology 2005;32(2):109-16.
2005: Jucaite Aurelija; Fernell Elisabeth; Halldin Christer; Forssberg Hans; Farde Lars
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Biological psychiatry 2005;57(3):229-38.
2005: Marchais-Oberwinkler Sandrine; Nowicki Bartek; Pike Victor W; Halldin Christer; Sandell Johan; Chou Yuan-Hwa; Gulyas Balazs; Brennum Lise T; Farde Lars; Wikström Håkan V
N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.
Bioorganic & medicinal chemistry 2005;13(3):883-93.
2005: Erixon-Lindroth Nina; Farde Lars; Wahlin Tarja-Brita Robins; Sovago Judit; Halldin Christer; Bäckman Lars
The role of the striatal dopamine transporter in cognitive aging.
Psychiatry research 2005;138(1):1-12.
2004: Cselényi Zsolt; Lundberg Johan; Halldin Christer; Farde Lars; Gulyás Balázs
Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.
Neurochemistry international 2004;45(5):773-81.
2004: Sóvágó Judit; Farde Lars; Halldin Christer; Langer Oliver; Laszlovszky István; Kiss Béla; Gulyás Balázs
Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
Neurochemistry international 2004;45(5):609-17.
2004: Talvik Mirjam; Nordström Anna-Lena; Larsen Niels-Erik; Jucaite Aurelija; Cervenka Simon; Halldin Christer; Farde Lars
A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.
Psychopharmacology 2004;175(2):148-53.
2004: Schou Magnus; Halldin Christer; Sóvágó Judit; Pike Victor W; Hall Håkan; Gulyás Balázs; Mozley P David; Dobson David; Shchukin E; Innis Robert B; Farde Lars
PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.
Synapse (New York, N.Y.) 2004;53(2):57-67.
2004: Varnäs Katarina; Halldin Christer; Hall Håkan
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
Human brain mapping 2004;22(3):246-60.
2004: Olsson Hans; Halldin Christer; Farde Lars
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
NeuroImage 2004;22(2):794-803.
2004: Yasuno Fumihiko; Suhara Tetsuya; Okubo Yoshiro; Sudo Yasuhiko; Inoue Makoto; Ichimiya Tetsuya; Takano Akihiro; Nakayama Kazuhiko; Halldin Christer; Farde Lars
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
The American journal of psychiatry 2004;161(6):1016-22.
2004: Savic I; Lindström P; Gulyás B; Halldin C; Andrée B; Farde L
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.
Neurology 2004;62(8):1343-51.
2004: Balle Thomas; Halldin Christer; Andersen Linus; Hjorth Alifrangis Lene; Badolo Lassina; Gjervig Jensen Klaus; Chou Yuan-Wha; Andersen Kim; Perregaard Jens; Farde Lars
New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and pet examination of brain uptake in the cynomolgus monkey.
Nuclear medicine and biology 2004;31(3):327-36.
2004: Larsen A K; Brennum L T; Egebjerg J; Sánchez C; Halldin C; Andersen P H
Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.
British journal of pharmacology 2004;141(6):1015-23.
2004: McCarron Julie A; Pike Victor W; Halldin Christer; Sandell Johan; Sóvágó Judit; Gulyas Balàsz; Cselényi Zsolt; Wikström Hakan V; Marchais-Oberwinkler Sandrine; Nowicki Bartek; Dollé Frédéric; Farde Lars
The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2004;6(1):17-26.
2004: Eskola Olli; Grönroos Tove; Bergman Jörgen; Haaparanta Merja; Marjamäki Päivi; Lehikoinen Pertti; Forsback Sarita; Langer Oliver; Hinnen Françoise; Dollé Frédéric; Halldin Christer; Solin Olof
A novel electrophilic synthesis and evaluation of medium specific radioactivity (1R,2S)-4-[18F]fluorometaraminol, a tracer for the assessment of cardiac sympathetic nerve integrity with PET.
Nuclear medicine and biology 2004;31(1):103-10.
2004: Halldin C; Gulyás B; Farde L
PET for drug development.
Ernst Schering Research Foundation workshop 2004;(48):95-109.
2003: Talvik Mirjam; Nordström Anna-Lena; Olsson Hans; Halldin Christer; Farde Lars
Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(4):361-70.
2003: Pike Victor W; Halldin Christer; Nobuhara Kenji; Hiltunen Julka; Mulligan Rachel S; Swahn Carl-Gunnar; Karlsson Per; Olsson Hans; Hume Susan P; Hirani Ella; Whalley Jaqueline; Pilowsky Lyn S; Larsson Stig; Schnell Per-Olof; Ell Peter J; Farde Lars
Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
European journal of nuclear medicine and molecular imaging 2003;30(11):1520-8.
2003: Schou Magnus; Halldin Christer; Sóvágó Judit; Pike Victor W; Gulyás Balázs; Mozley P David; Johnson David P; Hall Håkan; Innis Robert B; Farde Lars
Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.
Nuclear medicine and biology 2003;30(7):707-14.
2003: Halldin Christer; Erixon-Lindroth Nina; Pauli Stefan; Chou Yuan-Hwa; Okubo Yoshiro; Karlsson Per; Lundkvist Camilla; Olsson Hans; Guilloteau Denis; Emond Patrick; Farde Lars
[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
European journal of nuclear medicine and molecular imaging 2003;30(9):1220-30.
2003: Varnäs Katarina; Halldin Christer; Pike Victor W; Hall Håkan
Distribution of 5-HT4 receptors in the postmortem human brain--an autoradiographic study using [125I]SB 207710.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13(4):228-34.
2003: Karramkam Mylène; Hinnen Françoise; Berrehouma Myriam; Hlavacek Christophe; Vaufrey Françoise; Halldin Christer; McCarron Julie A; Pike Victor W; Dollé Frédéric
Synthesis of a [6-pyridinyl-18F]-labelled fluoro derivative of WAY-100635 as a candidate radioligand for brain 5-HT1A receptor imaging with PET.
Bioorganic & medicinal chemistry 2003;11(13):2769-82.
2003: Andrée Bengt; Hedman Ann; Thorberg Seth-Olav; Nilsson Dag; Halldin Christer; Farde Lars
Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain.
Psychopharmacology 2003;167(1):37-45.
2003: Chou Yuan-Hwa; Halldin Christer; Farde Lars
Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.
Psychopharmacology 2003;166(3):234-40.
2003: Chalon Sylvie; Tarkiainen Jari; Garreau Lucette; Hall Hakan; Emond Patrick; Vercouillie Johnny; Farde Lars; Dasse Philippe; Varnas Katarina; Besnard Jean-Claude; Halldin Christer; Guilloteau Denis
Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
The Journal of pharmacology and experimental therapeutics 2003;304(1):81-7.
2002: Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
Acta neurologica Scandinavica 2002;106(6):325-32.
2002: Sandell Johan; Yu Meixiang; Emond Patrick; Garreau Lucette; Chalon Sylvie; Någren Kjell; Guilloteau Denis; Halldin Christer
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.
Bioorganic & medicinal chemistry letters 2002;12(24):3611-3.
2002: Vas Adám; Sóvágó Judit; Halldin Christer; Sandell Johan; Karlsson Per; Kárpáti Egon; Kiss Béla; Cselényi Zsolt; Farde Lars; Gulyás Balázs
[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]
Orvosi hetilap 2002;143(47):2631-6.
2002: Bartenstein P; Asenbaum S; Catafau A; Halldin C; Pilowski L; Pupi A; Tatsch K;
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.
European journal of nuclear medicine and molecular imaging 2002;29(10):BP43-8.
2002: Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky L S; Pupi A;
European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.
European journal of nuclear medicine and molecular imaging 2002;29(10):BP36-42.
2002: Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky L S; Pupi A;
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.
European journal of nuclear medicine and molecular imaging 2002;29(10):BP30-5.
2002: Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky L S; Pupi A;
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.
European journal of nuclear medicine and molecular imaging 2002;29(10):BP23-9.
2002: Gulyás Balázs; Vas Adám; Halldin Christer; Sóvágó Judit; Sandell Johan; Olsson Hans; Fredriksson Anna; Stone-Elander Sharon; Farde Lars
Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.
Nuclear medicine and biology 2002;29(7):753-9.
2002: Sandell Johan; Halldin Christer; Sovago Judith; Chou Yuan-Hwa; Gulyás Balász; Yu Meixiang; Emond Patrick; Någren Kjell; Guilloteau Denis; Farde Lars
PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter.
Nuclear medicine and biology 2002;29(6):651-6.
2002: Gulyás Balázs; Halldin Christer; Sóvágó Judit; Sandell Johan; Cselényi Zsolt; Vas Adám; Kiss Béla; Kárpáti Egon; Farde Lars
Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
European journal of nuclear medicine and molecular imaging 2002;29(8):1031-8.
2002: Nyberg Svante; Olsson Hans; Nilsson Ulrika; Maehlum Eli; Halldin Christer; Farde Lars
Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole.
Psychopharmacology 2002;162(1):37-41.
2002: Drews A; Pietzsch H-J; Syhre R; Seifert S; Varnäs K; Hall H; Halldin C; Kraus W; Karlsson P; Johnsson C; Spies H; Johannsen B
Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Nuclear medicine and biology 2002;29(4):389-98.
2002: Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch H-J; Seifert S; Brust P; Johannsen B
Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Nuclear medicine and biology 2002;29(4):375-87.
2002: Karlsson Per; Farde Lars; Halldin Christer; Sedvall Göran
PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
The American journal of psychiatry 2002;159(5):761-7.
2002: Nyberg Svante; Chou Yuan-Hwa; Halldin Christer
Saturation of striatal D(2) dopamine receptors by clozapine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2002;5(1):11-6.
2002: Langer Oliver; Halldin Christer
PET and SPET tracers for mapping the cardiac nervous system.
European journal of nuclear medicine and molecular imaging 2002;29(3):416-34.
2002: Andrée Bengt; Halldin Christer; Pike Victor W; Gunn Roger N; Olsson Hans; Farde Lars
The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(3):292-303.
2002: Emond Patrick; Vercouillie Johnny; Innis Robert; Chalon Sylvie; Mavel Sylvie; Frangin Yves; Halldin Christer; Besnard Jean-Claude; Guilloteau Denis
Substituted diphenyl sulfides as selective serotonin transporter ligands: synthesis and in vitro evaluation.
Journal of medicinal chemistry 2002;45(6):1253-8.
2002: Sandell Johan; Halldin Christer; Chou Yuan-Hwa; Swahn Carl-Gunnar; Thorberg Seth-Olov; Farde Lars
PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor.
Nuclear medicine and biology 2002;29(1):39-45.
2002: Suhara Tetsuya; Okubo Yoshiro; Yasuno Fumihiko; Sudo Yasuhiko; Inoue Makoto; Ichimiya Tetsuya; Nakashima Yoshifumi; Nakayama Kazuhiko; Tanada Shuji; Suzuki Kazutoshi; Halldin Christer; Farde Lars
Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
Archives of general psychiatry 2002;59(1):25-30.
2002: Hall H; Varnäs K; Sandell J; Halldin C; Farde L; Vas A; Kárpáti E; Gulyás B
Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain.
Acta biologica Hungarica 2002;53(1-2):59-66.
2001: Halldin C; Gulyás B; Farde L
PET studies with carbon-11 radioligands in neuropsychopharmacological drug development.
Current pharmaceutical design 2001;7(18):1907-29.
2001: Sudo Y; Suhara T; Inoue M; Ito H; Suzuki K; Saijo T; Halldin C; Farde L
Reproducibility of [11 C]FLB 457 binding in extrastriatal regions.
Nuclear medicine communications 2001;22(11):1215-21.
2001: Halldin C
Serotonin 5-HT1A receptor imaging in the human brain with positron-emission tomography: coordination and the standardization and dissemination of methodology.
Journal of clinical pharmacology 2001;Suppl():95S.
2001: Halldin C; Gulyás B; Langer O; Farde L
Brain radioligands--state of the art and new trends.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(2):139-52.
2001: Talvik M; Nordström A L; Nyberg S; Olsson H; Halldin C; Farde L
No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
The American journal of psychiatry 2001;158(6):926-30.
2001: Marchais S; Nowicki B; Wikström H; Brennum L T; Halldin C; Pike V W
Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonists.
Bioorganic & medicinal chemistry 2001;9(3):695-702.
2001: Langer O; Dollé F; Valette H; Halldin C; Vaufrey F; Fuseau C; Coulon C; Ottaviani M; Någren K; Bottlaender M; Maziére B; Crouzel C
Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart.
Bioorganic & medicinal chemistry 2001;9(3):677-94.
2001: Ito H; Sudo Y; Suhara T; Okubo Y; Halldin C; Farde L
Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain.
NeuroImage 2001;13(3):531-9.
2001: Sandell J; Halldin C; Pike V W; Chou Y H; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström H V; Swahn C G; Farde L
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Nuclear medicine and biology 2001;28(2):177-85.
2001: Nobuhara K; Farde L; Halldin C; Karlsson P; Swahn C G; Olsson H; Bergström K A; Larsson S A; Schnell P O; McPherson D W; Savonen A; Hiltunen J; Sedvall G
SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP.
European journal of nuclear medicine 2001;28(1):13-24.
2001: Pike V W; Halldin C; Wikström H V
Radioligands for the study of brain 5-HT1A receptors in vivo.
Progress in medicinal chemistry 2001;38():189-247.
2000: Hall H; Farde L; Halldin C; Lundkvist C; Sedvall G
Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
Synapse (New York, N.Y.) 2000;38(4):421-31.
2000: Langer O; Halldin C; Chou Y; Sandell J; Swahn C; Någren K; Perrone R; Berardi F; Leopoldo M; Farde L
Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
Nuclear medicine and biology 2000;27(8):707-14.
2000: Chou Y H; Halldin C; Farde L
Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
Synapse (New York, N.Y.) 2000;38(2):138-43.
2000: Andrée B; Halldin C; Thorberg S O; Sandell J; Farde L
Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
Nuclear medicine and biology 2000;27(5):515-21.
2000: Pike V W; Halldin C; Wikström H; Marchais S; McCarron J A; Sandell J; Nowicki B; Swahn C G; Osman S; Hume S P; Constantinou M; Andrée B; Farde L
Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.
Nuclear medicine and biology 2000;27(5):449-55.
2000: Pinborg L H; Videbaek C; Knudsen G M; Swahn C G; Halldin C; Friberg L; Paulson O B; Lassen N A
Dopamine D(2) receptor quantification in extrastriatal brain regions using [(123)I]epidepride with bolus/infusion.
Synapse (New York, N.Y.) 2000;36(4):322-9.
2000: Langer O; Valette H; Dollé F; Halldin C; Loc'h C; Fuseau C; Coulon C; Ottaviani M; Bottlaender M; Mazière B; Crouzel C
High specific radioactivity (1R,2S)-4-[(18)F]fluorometaraminol: a PET radiotracer for mapping sympathetic nerves of the heart.
Nuclear medicine and biology 2000;27(3):233-8.
2000: Kaasinen V; Någren K; Hietala J; Oikonen V; Vilkman H; Farde L; Halldin C; Rinne J O
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
Neurology 2000;54(7):1482-7.
2000: Bäckman L; Ginovart N; Dixon R A; Wahlin T B; Wahlin A; Halldin C; Farde L
Age-related cognitive deficits mediated by changes in the striatal dopamine system.
The American journal of psychiatry 2000;157(4):635-7.
2000: Farde L; Andrée B; Ginovart N; Halldin C; Thorberg S
PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(4):422-9.
2000: Talvik-Lotfi M; Nyberg S; Nordström A L; Ito H; Halldin C; Brunner F; Farde L
High 5HT2A receptor occupancy in M100907-treated schizophrenic patients.
Psychopharmacology 2000;148(4):400-3.
2000: Nobuhara K; Halldin C; Hall H; Karlsson P; Farde L; Hiltunen J; McPherson D W; Savonen A; Bergström K A; Pauli S; Swahn C G; Larsson S A; Schnell P O; Sedvall G
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
Psychopharmacology 2000;149(1):45-55.
2000: Bergström K A; Yu M; Kuikka J T; Akerman K K; Hiltunen J; Lehtonen J; Halldin C; Tiihonen J
Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography.
European journal of nuclear medicine 2000;27(2):206-8.
2000: Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang D R; Slifstein M; Anjilvel S; Pidcock J; Guo N N; Lombardo I; Mann J J; Van Heertum R; Foged C; Halldin C; Laruelle M
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(2):225-43.
2000: Osterlund M K; Halldin C; Hurd Y L
Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain.
Synapse (New York, N.Y.) 2000;35(1):39-44.
1999: Okubo Y; Olsson H; Ito H; Lofti M; Suhara T; Halldin C; Farde L
PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457.
NeuroImage 1999;10(6):666-74.
1999: Bergström K A; Halldin C; Savonen A; Okubo Y; Hiltunen J; Nobuhara K; Swahn C G; Karlsson P; McPherson D; Knapp F F; Larsson S; Schnell P O; Farde L
Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
European journal of nuclear medicine 1999;26(11):1482-5.
1999: Gulyás B; Halldin C; Karlsson P; Chou Y H; Swahn C G; Bönöck P; Paróczai M; Farde L
Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 1999;9(4):217-22.
1999: Olsson H; Halldin C; Swahn C G; Farde L
Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(10):1164-73.
1999: Chou Y H; Karlsson P; Halldin C; Olsson H; Farde L
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Psychopharmacology 1999;146(2):220-7.
1999: Langer O; Halldin C; Dollé F; Swahn C G; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
Nuclear medicine and biology 1999;26(5):509-18.
1999: Lundkvist C; Loc'h C; Halldin C; Bottlaender M; Ottaviani M; Coulon C; Fuseau C; Mathis C; Farde L; Mazière B
Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter.
Nuclear medicine and biology 1999;26(5):501-7.
1999: Helfenbein J; Sandell J; Halldin C; Chalon S; Emond P; Okubo Y; Chou Y H; Frangin Y; Douziech L; Gareau L; Swahn C G; Besnard J C; Farde L; Guilloteau D
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Nuclear medicine and biology 1999;26(5):491-9.
1999: Gulyás B; Halldin C; Karlsson P; Chou Y H; Swahn C G; Bönöczk P; Farde L
[Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies]
Orvosi hetilap 1999;140(30):1687-91.
1999: Andrée B; Thorberg S O; Halldin C; Farde L
Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography.
Psychopharmacology 1999;144(3):303-5.
1999: Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
The American journal of psychiatry 1999;156(6):869-75.
1999: Lundkvist C; Halldin C; Swahn C G; Ginovart N; Farde L
Different brain radioactivity curves in a PET study with [11C]beta-CIT labelled in two different positions.
Nuclear medicine and biology 1999;26(4):343-50.
1999: Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang D R; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann J J; Foged C; Halldin C; Laruelle M
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Synapse (New York, N.Y.) 1999;32(2):93-109.
1999: Sandell J; Halldin C; Hall H; Thorberg S O; Werner T; Sohn D; Sedvall G; Farde L
Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor.
Nuclear medicine and biology 1999;26(2):159-64.
1999: Ginovart N; Farde L; Halldin C; Swahn C G
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Synapse (New York, N.Y.) 1999;31(2):154-62.
1999: Ito H; Okubo Y; Halldin C; Farde L
Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
NeuroImage 1999;9(2):235-42.
1999: Ito H; Halldin C; Farde L
Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):102-9.
1999: Hall H; Halldin C; Guilloteau D; Chalon S; Emond P; Besnard J; Farde L; Sedvall G
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I.
NeuroImage 1999;9(1):108-16.
1998: Halldin C; Foged C; Chou Y H; Karlsson P; Swahn C G; Sandell J; Sedvall G; Farde L
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2061-8.
1998: Hall H; Halldin C; Farde L; Sedvall G
Whole hemisphere autoradiography of the postmortem human brain.
Nuclear medicine and biology 1998;25(8):715-9.
1998: Farde L; Ito H; Swahn C G; Pike V W; Halldin C
Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1965-71.
1998: Ito H; Hietala J; Blomqvist G; Halldin C; Farde L
Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1998;18(9):941-50.
1998: Andrée B; Nyberg S; Ito H; Ginovart N; Brunner F; Jaquet F; Halldin C; Farde L
Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
Journal of clinical psychopharmacology 1998;18(4):317-23.
1998: Nordström A L; Olsson H; Halldin C
A PET study of D2 dopamine receptor density at different phases of the menstrual cycle.
Psychiatry research 1998;83(1):1-6.
1998: Foged C; Halldin C; Swahn C G; Ginovart N; Karlsson P; Lundkvist C; Farde L
[11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
Nuclear medicine and biology 1998;25(5):503-8.
1998: Emond P; Farde L; Chalon S; Belzung C; Mauclaire V; Chiron J P; Halldin C; Besnard J C; Guilloteau D
Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECT.
Nuclear medicine and biology 1998;25(4):405-9.
1998: Savic I; Blomqvist G; Halldin C; Litton J E; Gulyas B
Regional increases in [11C]flumazenil binding after epilepsy surgery.
Acta neurologica Scandinavica 1998;97(5):279-86.
1998: Kuikka J T; Baulieu J L; Hiltunen J; Halldin C; Bergström K A; Farde L; Emond P; Chalon S; Yu M; Nikula T; Laitinen T; Karhu J; Tupala E; Hallikainen T; Kolehmainen V; Mauclaire L; Maziere B; Tiihonen J; Guilloteau D
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.
European journal of nuclear medicine 1998;25(5):531-4.
1998: Osman S; Lundkvist C; Pike V W; Halldin C; McCarron J A; Swahn C G; Farde L; Ginovart N; Luthra S K; Gunn R N; Bench C J; Sargent P A; Grasby P M
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Nuclear medicine and biology 1998;25(3):215-23.
1998: Bergström K A; Halldin C; Hiltunen J; Swahn C G; Ito H; Ginovart N; Hall H; McPherson D W; Knapp F F; Larsson S; Schnell P O; Farde L
Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain.
Nuclear medicine and biology 1998;25(3):209-14.
1998: Pike V W; Halldin C; McCarron J A; Lundkvist C; Hirani E; Olsson H; Hume S P; Karlsson P; Osman S; Swahn C G; Hall H; Wikström H; Mensonidas M; Poole K G; Farde L
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
European journal of nuclear medicine 1998;25(4):338-46.
1998: Nyberg S; Nilsson U; Okubo Y; Halldin C; Farde L
Implications of brain imaging for the management of schizophrenia.
International clinical psychopharmacology 1998;13 Suppl 3():S15-20.
1998: Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):208-14.
1998: Hiltunen J; Akerman K K; Kuikka J T; Bergström K A; Halldin C; Nikula T; Räsänen P; Tiihonen J; Vauhkonen M; Karhu J; Kupila J; Länsimies E; Farde L
Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography.
European journal of nuclear medicine 1998;25(1):19-23.
1997: Farde L; Suhara T; Nyberg S; Karlsson P; Nakashima Y; Hietala J; Halldin C
A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
Psychopharmacology 1997;133(4):396-404.
1997: Günther I; Hall H; Halldin C; Swahn C G; Farde L; Sedvall G
[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain.
Nuclear medicine and biology 1997;24(7):629-34.
1997: Lundkvist C; Halldin C; Ginovart N; Swahn C G; Farde L
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.
Nuclear medicine and biology 1997;24(7):621-7.
1997: Nyberg S; Farde L; Halldin C
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
Archives of general psychiatry 1997;54(10):953-8.
1997: Foged C; Halldin C; Loc'h C; Mazière B; Pauli S; Maziére M; Hansen H C; Suhara T; Swahn C G; Karlsson P; Farde L
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography.
European journal of nuclear medicine 1997;24(10):1261-7.
1997: Farde L; Ginovart N; Ito H; Lundkvist C; Pike V W; McCarron J A; Halldin C
PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
Psychopharmacology 1997;133(2):196-202.
1997: Hall H; Halldin C; Jerning E; Osterlund M; Farde L; Sedvall G
Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors.
Nuclear medicine and biology 1997;24(5):389-93.
1997: Andrée B; Halldin C; Vrijmoed-de Vries M; Farde L
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men.
Psychopharmacology 1997;131(4):339-45.
1997: Bergström K A; Halldin C; Hall H; Lundkvist C; Ginovart N; Swahn C G; Farde L
In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
European journal of nuclear medicine 1997;24(6):596-601.
1997: Kuikka J T; Akerman K K; Hiltunen J; Bergström K A; Räsänen P; Vanninen E; Halldin C; Tiihonen J
Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography.
European journal of nuclear medicine 1997;24(5):483-7.
1997: Ginovart N; Farde L; Halldin C; Swahn C G
Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
Synapse (New York, N.Y.) 1997;25(4):321-5.
1997: Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn C G; Pauli S; Sedvall G
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
Brain : a journal of neurology 1997;120 ( Pt 3)():503-14.
1997: Farde L; Mack R J; Nyberg S; Halldin C
D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects.
International clinical psychopharmacology 1997;12 Suppl 1():S3-7.
1997: Hall H; Lundkvist C; Halldin C; Farde L; Pike V W; McCarron J A; Fletcher A; Cliffe I A; Barf T; Wikström H; Sedvall G
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
Brain research 1997;745(1-2):96-108.
1997: Nyberg S; Farde L; Halldin C
A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(1):1-7.
1996: Hall H; Halldin C; Dijkstra D; Wikström H; Wise L D; Pugsley T A; Sokoloff P; Pauli S; Farde L; Sedvall G
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
Psychopharmacology 1996;128(3):240-7.
1996: Nyberg S; Farde L; Halldin C
Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Psychiatry research 1996;67(3):163-71.
1996: Foged C; Halldin C; Loc'h C; Mazière B; Karlsson P; Mazière M; Swahn C G; Farde L
11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
Nuclear medicine and biology 1996;23(6):837-44.
1996: Loc'h C; Halldin C; Bottlaender M; Swahn C G; Moresco R M; Mazière M; Farde L; Mazière B
Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET.
Nuclear medicine and biology 1996;23(6):813-9.
1996: Osman S; Lundkvist C; Pike V W; Halldin C; McCarron J A; Swahn C G; Ginovart N; Luthra S K; Bench C J; Grasby P M; Wikström H; Barf T; Cliffe I A; Fletcher A; Farde L
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
Nuclear medicine and biology 1996;23(5):627-34.
1996: Farde L; Suhara T; Halldin C; Nybäck H; Nakashima Y; Swahn C G; Karlsson P; Ginovart N; Bymaster F P; Shannon H E; Foged C; Suzdak P D; Sauerberg P
PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man.
Dementia (Basel, Switzerland) 1996;7(4):187-95.
1996: Kuikka J T; Hiltunen J; Foged C; Bergström K A; Halldin C; Akerman K; Tiihonen J; Farde L
Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)- 7-iodo-5, 6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241).
European journal of nuclear medicine 1996;23(7):798-803.
1996: Hall H; Farde L; Halldin C; Hurd Y L; Pauli S; Sedvall G
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride.
Synapse (New York, N.Y.) 1996;23(2):115-23.
1996: Nyberg S; Nakashima Y; Nordström A L; Halldin C; Farde L
Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.
The British journal of psychiatry. Supplement 1996;(29):40-4.
1996: Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn C G
[11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
Synapse (New York, N.Y.) 1996;22(4):386-90.
1996: Någren K; Halldin C; Swahn C G; Suhara T; Farde L
[11C]metaraminol, a false neurotransmitter: preparation, metabolite studies and positron emission tomography examination in monkey.
Nuclear medicine and biology 1996;23(3):221-7.
1996: Foged C; Halldin C; Hiltunen J; Braestrup C; Thomsen C; Hansen H C; Suhara T; Pauli S; Swahn C G; Karlsson P; Larsson S; Farde L
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding.
Nuclear medicine and biology 1996;23(3):201-9.
1996: Suhara T; Farde L; Halldin C; Någren K; Karlsson P
Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PET.
Annals of nuclear medicine 1996;10(1):85-8.
1996: Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn C G; Carr A A; Brunner F; Farde L
[11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
Life sciences 1996;58(10):PL 187-92.
1995: Maziere B; Loc'h C; Müller L; Halldin C
76Br-beta-CBT, a PET tracer for investigating dopamine neuronal uptake.
Nuclear medicine and biology 1995;22(8):993-7.
1995: Bergström K A; Halldin C; Kuikka J T; Swahn C G; Tiihonen J; Hiltunen J; Länsimies E; Farde L
The metabolite pattern of [123I]beta-CIT determined with a gradient HPLC method.
Nuclear medicine and biology 1995;22(8):971-6.
1995: Någren K; Halldin C; Müller L; Swahn C G; Lehikoinen P
Comparison of [11C]methyl triflate and [11C]methyl iodide in the synthesis of PET radioligands such as [11C]beta-CIT and [11C]beta-CFT.
Nuclear medicine and biology 1995;22(8):965-79.
1995: Ametamey S M; Halldin C; Swahn C G; Hall H; Schubiger P A; Farde L
Synthesis of nor-beta-CIT, beta-CIT and trimethylstannyl-beta-CT.
Nuclear medicine and biology 1995;22(8):959-64.
1995: Farde L; Halldin C; Någren K; Karlsson P; Swahn C G; Suhara T
PET examination of the monkey heart with high specific radioactivity [11C]norepinephrine and [11C]metaraminol.
Nuclear medicine and biology 1995;22(8):1053-6.
1995: Swahn C G; Halldin C; Någren K; Farde L
An HPLC-method for determination of ligand metabolism during PET studies with [11C]metaraminol and [11C]norepinephrine.
Nuclear medicine and biology 1995;22(8):1045-8.
1995: Någren K; Halldin C; Swahn C G; Schoeps K O; Langer O; Mitterhauser M; Zolle I
Some new methods for the synthesis of cardiac neurotransmission PET radiotracers.
Nuclear medicine and biology 1995;22(8):1037-43.
1995: Nyberg S; Farde L; Bartfai A; Halldin C
Central D2 receptor occupancy and effects of zuclopenthixol acetate in humans.
International clinical psychopharmacology 1995;10(4):221-7.
1995: Karlsson P; Sedvall G; Halldin C; Swahn C G; Farde L
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
Psychopharmacology 1995;121(3):300-8.
1995: Lundkvist C; Halldin C; Swahn C G; Hall H; Karlsson P; Nakashima Y; Wang S; Milius R A; Neumeyer J L; Farde L
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.
Nuclear medicine and biology 1995;22(7):905-13.
1995: Nordström A L; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
The American journal of psychiatry 1995;152(10):1444-9.
1995: Nyberg S; Nordström A L; Halldin C; Farde L
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.
International clinical psychopharmacology 1995;10 Suppl 3():81-5.
1995: Müller L; Hall H; Halldin C; Farde L; Hohlweg R; Suzdak P D; Nielsen E B; Foged C
Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system.
Nuclear medicine and biology 1995;22(6):711-7.
1995: Nordström A L; Farde L; Eriksson L; Halldin C
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Psychiatry research 1995;61(2):67-83.
1995: Halldin C; Farde L; Högberg T; Mohell N; Hall H; Suhara T; Karlsson P; Nakashima Y; Swahn C G
Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1275-81.
1995: Farde L; Hall H; Pauli S; Halldin C
Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
Synapse (New York, N.Y.) 1995;20(3):200-8.
1995: Brené S; Hall H; Lindefors N; Karlsson P; Halldin C; Sedvall G
Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.
Neuroscience 1995;67(1):37-48.
1995: Nyberg S; Dahl M L; Halldin C
A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
Psychopharmacology 1995;119(3):345-8.
1995: Karlsson P; Farde L; Halldin C; Sedvall G; Ynddal L; Sloth-Nielsen M
Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man.
Psychopharmacology 1995;119(1):1-8.
1995: Müller L; Halldin C; Foged C; Hohlweg R
Synthesis of [18F]NNC 12-0817 and [18F]NNC 12-0818; two potential radioligands for the dopamine transporter.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1995;46(5):323-8.
1995: Bergström K A; Halldin C; Kuikka J T; Swahn C G; Tiihonen J; Hiltunen J; Länsimies E; Farde L
Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter.
Synapse (New York, N.Y.) 1995;19(4):297-300.
1995: Hall H; Halldin C; Nyberg S; Farde L; Sedvall G
Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(1):19-25.
1995: Nyberg S; Farde L; Halldin C; Dahl M L; Bertilsson L
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.
The American journal of psychiatry 1995;152(2):173-8.
1995: Någren K; Müller L; Halldin C; Swahn C G; Lehikoinen P
Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate.
Nuclear medicine and biology 1995;22(2):235-9.
1995: Farde L; Nyberg S; Oxenstierna G; Nakashima Y; Halldin C; Ericsson B
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
Journal of clinical psychopharmacology 1995;15(1 Suppl 1):19S-23S.
1995: Sedvall G; Pauli S; Karlsson P; Farde L; Nordström A L; Nyberg S; Halldin C
PET imaging of neuroreceptors in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():25-30.
1995: Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström A L; Nyberg S; Pauli S
Utilization of radioligands in schizophrenia research.
Clinical neuroscience (New York, N.Y.) 1995;3(2):112-21.
1994: Hall H; Sedvall G; Magnusson O; Kopp J; Halldin C; Farde L
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(4):245-56.
1994: Farde L; Nordström A L; Nyberg S; Halldin C; Sedvall G
D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
The Journal of clinical psychiatry 1994;55 Suppl B():67-9.
1994: Nybäck H; Halldin C; Ahlin A; Curvall M; Eriksson L
PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.
Psychopharmacology 1994;115(1-2):31-6.
1994: Halldin C; Högberg T; Farde L
Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
Nuclear medicine and biology 1994;21(4):627-31.
1994: Blomqvist G; Seitz R J; Sjögren I; Halldin C; Stone-Elander S; Widén L; Solin O; Haaparanta M
Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography.
Acta physiologica Scandinavica 1994;151(1):29-43.
1994: Någren K; Schoeps K O; Halldin C; Swahn C G; Farde L
Selective synthesis of racemic 1-11C-labelled norepinephrine, octopamine, norphenylephrine and phenylethanolamine using [11C]nitromethane.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1994;45(4):515-21.
1994: Farde L; Halldin C; Någren K; Suhara T; Karlsson P; Schoeps K O; Swahn C G; Bone D
Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart.
European journal of nuclear medicine 1994;21(4):345-7.
1994: Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
Synapse (New York, N.Y.) 1994;16(2):93-103.
1994: Müller L; Halldin C; Foged C; Karlsson P; Hall H; Swahn C G; Suzdak P D; Hohlweg R; Nielsen E B; Farde L
Preparation of a potential positron emission tomographic radioligand for the dopamine transporter.
European journal of nuclear medicine 1994;21(2):131-7.
1994: Sedvall G; Karlsson P; Lundin A; Anvret M; Suhara T; Halldin C; Farde L
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.
European archives of psychiatry and clinical neuroscience 1994;243(5):249-55.
1994: Farde L; Pauli S; Litton J E; Halldin C; Neiman J; Sedvall G
PET-determination of benzodiazepine receptor binding in studies on alcoholism.
EXS 1994;71():143-53.
1993: Halldin C; Foged C; Farde L; Karlsson P; Hansen K; Grønvald F; Swahn C G; Hall H; Sedvall G
[11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Nuclear medicine and biology 1993;20(8):945-53.
1993: Schoeps K O; Halldin C; Någren K; Swahn C G; Karlsson P; Hall H; Farde L
Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primates.
Nuclear medicine and biology 1993;20(5):669-78.
1993: Pike V W; Halldin C; Crouzel C; Barré L; Nutt D J; Osman S; Shah F; Turton D R; Waters S L
Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status.
Nuclear medicine and biology 1993;20(4):503-25.
1993: Müller L; Halldin C; Farde L; Karlsson P; Hall H; Swahn C G; Neumeyer J; Gao Y; Milius R
[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.
Nuclear medicine and biology 1993;20(3):249-55.
1993: Litton J E; Neiman J; Pauli S; Farde L; Hindmarsh T; Halldin C; Sedvall G
PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls.
Psychiatry research 1993;50(1):1-13.
1993: Hall H; Halldin C; Sedvall G
Binding of [3H]SCH 39166 to human post mortem brain tissue.
Pharmacology & toxicology 1993;72(3):152-8.
1993: Nordström A L; Farde L; Wiesel F A; Forslund K; Pauli S; Halldin C; Uppfeldt G
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
Biological psychiatry 1993;33(4):227-35.
1993: Karlsson P; Farde L; Halldin C; Swahn C G; Sedvall G; Foged C; Hansen K T; Skrumsager B
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Psychopharmacology 1993;113(2):149-56.
1993: Nordström A L; Farde L; Halldin C
High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
Psychopharmacology 1993;110(3):365-7.
1993: Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Psychopharmacology 1993;110(3):265-72.
1992: Halldin C; Någren K; Swahn C G; Långström B; Nybäck H
(S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(8):871-80.
1992: Farde L; Nordström A L; Wiesel F A; Pauli S; Halldin C; Sedvall G
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
Archives of general psychiatry 1992;49(7):538-44.
1992: Mazière B; Coenen H H; Halldin C; Någren K; Pike V W
PET radioligands for dopamine receptors and re-uptake sites: chemistry and biochemistry.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(4):497-512.
1992: Hall H; Farde L; Halldin C; Högberg T; Larsson S; Sedvall G
Imaging of dopamine receptors using PET and SPECT.
Neurochemistry international 1992;20 Suppl():329S-333S.
1992: Hall H; Halldin C; Sedvall G
Gpp(NH)p stimulates [3H]raclopride binding to homogenates from human putamen and accumbens.
Neuroscience letters 1992;136(1):79-82.
1992: Nordström A L; Farde L; Halldin C
Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.
Psychopharmacology 1992;106(4):433-8.
1992: Sedvall C G; Farde L; Hall H; Halldin C; Karlsson P; Brene S; Lindefors N; Persson H; Chipkin R E; Ehrlich M
Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():466A-467A.
1992: Farde L; Nordström A L; Halldin C; Wiesel F A; Sedvall G
PET studies of dopamine receptors in relation to antipsychotic drug treatment.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():468A-469A.
1992: Halldin C; Farde L; Litton J E; Hall H; Sedvall G
[11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography.
Psychopharmacology 1992;108(1-2):16-22.
1992: Pauli S; Liljequist S; Farde L; Swahn C G; Halldin C; Litton J E; Sedvall G
PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.
Psychopharmacology 1992;107(2-3):180-5.
1991: Wiesel F A; Blomqvist G; Halldin C; Sjögren I; Bjerkenstedt L; Venizelos N; Hagenfeldt L
The transport of tyrosine into the human brain as determined with L-[1-11C]tyrosine and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(11):2043-9.
1991: Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
European journal of pharmacology 1991;201(1):1-10.
1991: Jossan S S; Gillberg P G; d'Argy R; Aquilonius S M; Långström B; Halldin C; Oreland L
Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl.
Brain research 1991;547(1):69-76.
1991: Köhler C; Ericson H; Högberg T; Halldin C; Chan-Palay V
Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298.
Neuroscience letters 1991;125(1):12-4.
1991: Persson A; d'Argy R; Gillberg P G; Halldin C; Litton J E; Swahn C G; Sedvall G
Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sections.
Journal of neuroscience methods 1991;36(1):53-61.
1991: Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(8):871-81.
1991: Sedvall G; Farde L; Barnett A; Hall H; Halldin C
11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET.
Psychopharmacology 1991;103(2):150-3.
1991: Hall H; Högberg T; Halldin C; Köhler C; Ström P; Ross S B; Larsson S A; Farde L
NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
Psychopharmacology 1991;103(1):6-18.
1991: Schoeps K O; Ram S; Ehrenkaufer R; Halldin C
Synthesis of [2-11C]glycine from [11C]nitromethane.
Acta radiologica. Supplementum 1991;376():95.
1991: Thorell J O; Stone-Elander S; Halldin C; Widén L
Synthesis of [1-11C]-beta-hydroxybutyric acid.
Acta radiologica. Supplementum 1991;376():94.
1991: Blomqvist G; Stone-Elander S; Halldin C; Roland P E; Swahn C G; Haaparanta M; Solin O; Lindqvist M; Widén L
Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
Acta radiologica. Supplementum 1991;376():171-2.
1991: Persson A; d'Argy R; Gillberg P G; Halldin C; Litton J L; Swahn C G; Sedvall G
Autoradiography and saturation experiments with 11C-RO 15-1788 binding to human brain.
Acta radiologica. Supplementum 1991;376():169-70.
1991: Halldin C; Farde L; Hall H; Högberg T; Printz G; Pulka W; Sedvall G; Solin O
Synthesis of five benzamide analogs. Comparison with positron emission tomography.
Acta radiologica. Supplementum 1991;376():121-2.
1991: Stone-Elander S; Halldin C; Långström B; Blomqvist G; Hamnqvist F; Printz G; Widén L
Production method for [11C]-D-glucose labeled in carbon-1 for positron emission tomography of glucose metabolism.
Acta radiologica. Supplementum 1991;376():102-3.
1991: Schoeps K O; Långström B; Stone-Elander S; Halldin C
Synthesis of [1-11C]D-glucose and [1-11C]D-mannose from on-line produced [11C]nitromethane.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(9):877-83.
1991: Stone-Elander S; Roland P; Schwenner E; Halldin C; Widén L
Synthesis of [isopropyl-11C]nimodipine for in vivo studies of dihydropyridine binding in man using positron emission tomography.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(9):871-5.
1991: Halldin C; Farde L; Barnett A; Sedvall G
Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1991;42(5):451-5.
1990: Hall H; Wedel I; Halldin C; Kopp J; Farde L
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Journal of neurochemistry 1990;55(6):2048-57.
1990: Blomqvist G; Stone-Elander S; Halldin C; Roland P E; Widén L; Lindqvist M; Swahn C G; Långström B; Wiesel F A
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1990;10(4):467-83.
1990: Farde L; Wiesel F A; Stone-Elander S; Halldin C; Nordström A L; Hall H; Sedvall G
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Archives of general psychiatry 1990;47(3):213-9.
1990: Halldin C; Farde L; Högberg T; Hall H; Sedvall G
Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1990;41(7):669-74.
1990: Blomqvist G; Pauli S; Farde L; Eriksson L; Persson A; Halldin C
Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.
European journal of nuclear medicine 1990;16(4-6):257-65.
1990: Högberg T; Ström P; Hall H; Köhler C; Halldin C; Farde L
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
Acta pharmaceutica Nordica 1990;2(1):53-60.
1989: Farde L; Eriksson L; Blomquist G; Halldin C
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1989;9(5):696-708.
1989: Stone-Elander S; Roland P; Halldin C; Hassan M; Seitz R
Synthesis of [11C]sodium thiocyanate for in vivo studies of anion kinetics using positron emission tomography (PET).
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(7):741-6.
1989: Nybäck H; Nordberg A; Långström B; Halldin C; Hartvig P; Ahlin A; Swahn C G; Sedvall G
Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography.
Progress in brain research 1989;79():313-9.
1989: Wiesel F A; Farde L; Halldin C
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
Acta psychiatrica Scandinavica. Supplementum 1989;352():30-4.
1989: Halldin C; Bjurling P; Stålnacke C G; Jossan S S; Oreland L; Långström B
11C-labelling of dimethylphenethylamine in two different positions and biodistribution studies.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1989;40(7):557-60.
1989: Schoeps K O; Stone-Elander S; Halldin C
On-line synthesis of [11C]nitroalkanes.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1989;40(3):261-2.
1989: Jossan S S; d'Argy R; Gillberg P G; Aquilonius S M; Långström B; Halldin C; Bjurling P; Stålnacke C G; Fowler J; MacGregor R
Localization of monoamine oxidase B in human brain by autoradiographical use of 11C-labelled L-deprenyl.
Journal of neural transmission 1989;77(1):55-64.
1988: Farde L; Wiesel F A; Halldin C; Sedvall G
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
Archives of general psychiatry 1988;45(1):71-6.
1988: Farde L; Pauli S; Hall H; Eriksson L; Halldin C; Högberg T; Nilsson L; Sjögren I; Stone-Elander S
Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
Psychopharmacology 1988;94(4):471-8.
1988: d'Argy R; Paul R; Frankenberg L; Stålnacke C G; Lundqvist H; Kangas L; Halldin C; Någren K; Roeda D; Haaparanta M
Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(5):577-85.
1988: Halldin C; Stone-Elander S; Thorell J O; Persson A; Sedvall G
11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1988;39(9):993-7.
1987: Arnett C D; Fowler J S; MacGregor R R; Schlyer D J; Wolf A P; Långström B; Halldin C
Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.
Journal of neurochemistry 1987;49(2):522-7.
1987: Farde L; Wiesel F A; Hall H; Halldin C; Stone-Elander S; Sedvall G
No D2 receptor increase in PET study of schizophrenia.
Archives of general psychiatry 1987;44(7):671-2.
1987: Långström B; Antoni G; Gullberg P; Halldin C; Malmborg P; Någren K; Rimland A; Svärd H
Synthesis of L- and D-[methyl-11C]methionine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(6):1037-40.
1987: Halldin C; Schoeps K O; Stone-Elander S; Wiesel F A
The Bücherer-Strecker synthesis of D- and L-(1-11C)tyrosine and the in vivo study of L-(1-11C)tyrosine in human brain using positron emission tomography.
European journal of nuclear medicine 1987;13(6):288-91.
1987: Watanabe Y; Långström B; Stålnacke C G; Gullberg P; Svärd H; Halldin C; Hayaishi O
Synthesis of 11C-labeled prostaglandins and positron emission tomography studies using the rhesus monkey.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():943-5.
1987: Farde L; Halldin C; Stone-Elander S; Sedvall G
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
Psychopharmacology 1987;92(3):278-84.
1986: Fowler J S; Arnett C D; Wolf A P; Shiue C Y; MacGregor R R; Halldin C; Långström B; Wagner H N
A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(3):281-4.
1986: Hartvig P; Eckernäs S A; Lindström L; Ekblom B; Bondesson U; Lundqvist H; Halldin C; Någren K; Långström B
Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).
Psychopharmacology 1986;89(2):248-52.
1986: Halldin C; Stone-Elander S; Farde L; Ehrin E; Fasth K J; Långström B; Sedvall G
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1986;37(10):1039-43.
1986: Sedvall G; Farde L; Stone-Elander S; Halldin C
Dopamine D1-receptor binding in the living human brain.
Advances in experimental medicine and biology 1986;204():119-24.
1986: Bergström M; Mosskin M; Ericson K; Ehrin E; Thorell J O; von Holst H; Norén G; Persson A; Halldin C; Stone-Elander S
Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography.
Acta radiologica. Supplementum 1986;369():409-11.
1985: MacGregor R R; Halldin C; Fowler J S; Wolf A P; Arnett C D; Langström B; Alexoff D
Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.
Biochemical pharmacology 1985;34(17):3207-10.
1985: Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
AJNR. American journal of neuroradiology 1985;6(4):505-14.
1985: Stålnacke C G; Sundell-Bergman S; Halldin C; Långström B
Radiotoxicity of 11C-methionine measured by the accumulation of DNA strand breaks in mammalian cells.
European journal of nuclear medicine 1985;11(5):166-70.
1984: Berglund L; Halldin C; Lilja A; Lindberg B S; Lundqvist H; Långström B; Malmborg P; Någren K; Stålnacke C G
11C-methionine kinetics in pregnant rhesus monkeys studied by positron emission tomography: a new approach to feto-maternal metabolism.
Acta obstetricia et gynecologica Scandinavica 1984;63(7):641-5.
1983: Bergström M; Collins V P; Ehrin E; Ericson K; Eriksson L; Greitz T; Halldin C; von Holst H; Långström B; Lilja A
Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine.
Journal of computer assisted tomography 1983;7(6):1062-6.

Sign-in to see more